What Does InMed Pharmaceuticals Do?

Total employees18
HeadquartersVancouver
Founded

InMed Pharmaceuticals Inc. is a global biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of rare cannabinoids and cannabinoid-based therapeutics. The company combines its validated drug development expertise with its IntegraSyn™ cannabinoid manufacturing approach to develop novel therapies for diseases with high unmet medical needs. InMed also operates InMed Biosciences, a B2B division focused on supplying high-quality, regulatory-compliant rare cannabinoids to the health and wellness sector, and includes its subsidiary BayMedica, which specializes in synthetic and biosynthetic cannabinoid production.

Where Is InMed Pharmaceuticals's Headquarters?

HQ Function

The Vancouver headquarters serves as the primary center for corporate administration, strategic planning, financial operations, clinical development oversight, regulatory affairs, and business development activities.

Notable Features:

Located in a prominent business area, offering access to Vancouver's robust life sciences community, financial institutions, and transportation links.

Work Culture:

InMed fosters a dynamic, science-driven, and collaborative work environment. The culture emphasizes innovation, scientific rigor, and a commitment to developing solutions for unmet medical needs.

HQ Significance:

The headquarters is crucial for InMed's strategic decision-making, management of its global R&D programs, and engagement with the North American and international investment communities (listed on NASDAQ and TSX).

Values Reflected in HQ: The headquarters reflects InMed's commitment to scientific excellence, innovation in cannabinoid research, and a patient-focused approach to drug development.

Location:

InMed Pharmaceuticals operates with a global perspective, headquartered in Canada and with R&D and subsidiary operations in the United States (California and Nevada). The company collaborates with Contract Manufacturing Organizations (CMOs) in the US and Europe for GMP-compliant production of cannabinoids. Its pharmaceutical development programs target global regulatory approvals, and its InMed Biosciences division markets rare cannabinoids to the international health and wellness industry.

Street Address:

Suite 350 – 409 Granville Street

City:

Vancouver

State/Province:

British Columbia

Country:

Canada

Where Else Does InMed Pharmaceuticals Operate Around the World?

Vancouver, British Columbia, Canada

Address: c/o University of British Columbia, 2329 West Mall, Vancouver, BC V6T 1Z4, Canada (Leased Lab Space)

Facilitates access to advanced research infrastructure, academic collaborations, and a skilled talent pool within one of Canada's leading research universities, supporting InMed's early-stage R&D pipeline.

Novato, California, USA

Address: Leased lab facility in Novato, CA (e.g., historically 100 Wood Hollow Dr, Novato, CA 94945 - specific current leased address may vary)

Strengthens InMed's cannabinoid manufacturing capabilities and R&D in the U.S., leveraging California's prominent biotech ecosystem and serving as a key site for producing rare cannabinoids.

Las Vegas, Nevada, USA

Address: 9605 S. Eastern Avenue, Suite 240, Las Vegas, Nevada 89123, USA

Provides an administrative base for BayMedica's operations within the United States.

Buying Intent Signals for InMed Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading InMed Pharmaceuticals? Meet the Executive Team

As of April 2025, InMed Pharmaceuticals' leadership includes:

Eric A. Adams - President & Chief Executive Officer
Alexandra D.J. Mancini - SVP, Clinical Development & Regulatory Affairs
Jonathan Tegge, CPA, CA - Chief Financial Officer
Michael Woudenberg, Ph.D. - VP, Chemistry, Manufacturing & Controls (CMC)

Who's Investing in InMed Pharmaceuticals?

InMed Pharmaceuticals has been backed by several prominent investors over the years, including:

Publicly Traded (NASDAQ: INM, TSX: IN)
Empery Asset Management, LP
CVI Investments, Inc.
Other institutional and retail investors

What Leadership Changes Has InMed Pharmaceuticals Seen Recently?

Hire1
Exits0

In the past 12 months, InMed Pharmaceuticals appointed Jonathan Tegge as its new Chief Financial Officer in August 2023. No other major executive departures or hires at the senior executive level have been publicly announced during this period.

New Appointments:

Jonathan Tegge, Jonathan Tegge appointed as new Chief Financial Officer to lead InMed's financial strategy and operations.

What Technology (Tech Stack) Is Used byInMed Pharmaceuticals?

Discover the tools InMed Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

InMed Pharmaceuticals Email Formats and Examples

While InMed Pharmaceuticals does not officially publish its email format, a common pattern used by companies in the biopharmaceutical industry, and potentially by InMed, is [first_initial][last_name]@[company_domain].com. For example, 'jdoe@inmedpharma.com'.

[first_initial][last]@inmedpharma.com

Format

eadams@inmedpharma.com

Example

70%

Success rate

What's the Latest News About InMed Pharmaceuticals?

GlobeNewswire via InMed Pharmaceuticals WebsiteMay 15, 2024

InMed Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Business Update

InMed Pharmaceuticals announced its financial results for the third quarter of fiscal year 2024, ended March 31, 2024. The company provided updates on its pharmaceutical drug development programs, including INM-901 for Alzheimer's disease and INM-089 for epidermolysis bullosa, and highlighted progress in its cannabinoid manufacturing activities and commercial B2B sales....more

GlobeNewswire via InMed Pharmaceuticals WebsiteJanuary 23, 2024

InMed Pharmaceuticals Launches Delta 9-Dominant Tetrahydrocannabivarin (Δ9-THCV) into the Health and Wellness Market

InMed Pharmaceuticals announced the commercial launch of Delta 9-dominant Tetrahydrocannabivarin (Δ9-THCV) through its B2B subsidiary, InMed Biosciences. This launch expands its portfolio of rare cannabinoids available for use in the health and wellness sector, manufactured to high quality and regulatory standards....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including InMed Pharmaceuticals, are just a search away.